Skip to content
To the full analysis

Swedish Orphan Biovitrum stock: balance sheet and debt

SOBI.ST
$48.83Closing price of 12 Nov 2026MEQIRI Score 75 out of 100

Swedish Orphan Biovitrum has a debt to equity ratio of 0.3 and an interest coverage of 1x.

Daily figure as of 13 Nov 2026

Debt / Equity
0.3
Interest coverage
1x
Current ratio
0.9
Cash & equivalents
$104.38M
Total assets
$6.76B
Equity ratio
55.9%
Goodwill
$904.85M
Plus intangible assets of $4.02B
Net debt
$1.05B

Total assets and equity ratio

How large the balance sheet of Swedish Orphan Biovitrum AB is, how much of it is equity and how much is goodwill from acquisitions.

Equity ratio

Figures as a table
YearTotal assetsGoodwill and intangible assetsof which goodwillEquity ratioNet debt
2006$208.33M$47.42M$4.13M66.5%−$68.16M
2007$195.36M$54.22M$3.95M74.6%−$67.58M
2008$258.58M$102.88Mnot split out49.8%−$46.13M
2009$281.31M$116.23Mnot split out48.2%−$25.73M
2010$708.88M$523.85Mnot split out61.4%$269.61M
2011$671.77M$489.83M$160.97M74.1%$48.23M
2012$633.56M$454.57M$160.97M76.6%$14.34M
2013$653.7M$464.96M$165.28M73.2%$34.66M
2014$638.8M$425.9M$155.84M71.0%$27.34M
2015$833.33M$580.27M$155.84M56.4%−$10.88M
2016$1B$682.45M$155.84M53.7%$202.75M
2017$1.09B$646.26M$155.84M61.5%$17.37M
2018$1.72B$1.02B$155.84M52.6%−$300.39M
2019$4.58B$3.75B$669.61M37.1%$1.59B
2020$4.84B$3.89B$588.89M41.8%$1.42B
2021$4.88B$3.85B$630.51M47.7%$988.78M
2022$5.26B$4.01B$702.6M50.5%$776.1M
2023$7.42B$6.03B$966.82M45.7%$1.96B
2024$7.56B$5.91B$1.05B53.4%$1.56B
2025$6.76B$4.92B$904.85M55.9%$1.05B

The equity ratio divides total equity, including non-controlling interests, by total assets. Net debt is debt minus cash and short-term investments; a negative figure means cash exceeds debt. In years without separate goodwill, the table shows the sum of goodwill and intangible assets, because the data do not list goodwill separately there.

Equity and debt

What the company owns and owes

  • Cash & equivalents
  • Equity
  • Debt
Figures as a table
YearCash & equivalentsEquityDebtDebt / Equity
2006$90.63M$138.55M$22.47M0.16
2007$76.24M$145.67M$8.66M0.06
2008$46.13M$128.85M$00
2009$30.75M$135.65M$5.01M0.04
2010$3.86M$435.42M$273.47M0.63
2011$21.96M$497.69M$70.19M0.14
2012$45.82M$485.11M$60.16M0.12
2013$44.63M$478.22M$79.29M0.17
2014$52.06M$453.51M$79.39M0.18
2015$90.61M$470.21M$79.73M0.17
2016$78.79M$536.88M$281.55M0.52
2017$148.25M$671.87M$165.63M0.25
2018$300.69M$906.46M$299.91K0
2019$73.9M$1.7B$1.66B0.98
2020$40.51M$2.03B$1.46B0.72
2021$104.78M$2.33B$1.09B0.47
2022$136.47M$2.66B$912.57M0.34
2023$90.65M$3.4B$2.05B0.6
2024$114.31M$4.04B$1.68B0.42
2025$104.38M$3.78B$1.15B0.3

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Currency
Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = SEK 9.9729)
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Strong, published since 7 Nov 2026 (in the score history since 29 Oct 2026)
  • Valuation signal Undervalued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy